Megan Sperry graduated from Boston University in 2012 with a B.S. in Biomedical Engineering. She obtained an M.Phil from Imperial College London in 2014 and Ph.D. in Bioengineering from the University of Pennsylvania in 2019. Her doctoral work characterized central nervous system processes that contribute to the development of persistent temporomandibular (TMJ) pain, using principles from complex network analysis and graph theory to model changes in brain function. Megan joined the Wyss Institute in 2019 as a Research Fellow in Michael Levin’s lab and and worked collaboratively with Donald Ingber’s group. Her work focuses on the integration of computational drug prediction with whole-organism screening approaches for drug repurposing and novel therapeutics development. Working across multiple application areas, Megan is driving efforts to leverage complex system analyses and multi-omics to more efficiently design therapies and maximize translational impact.